TY - JOUR
T1 - Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users
AU - Jenness, Samuel M.
AU - Neaigus, Alan
AU - Hagan, Holly
AU - Murrill, Christopher S.
AU - Wendel, Travis
PY - 2010/3/1
Y1 - 2010/3/1
N2 - Sex partnerships with injection drug users (IDU) are an understudied network-level risk factor for heterosexual HIV infection. Heterosexuals with no history of injection were recruited from high-risk areas in New York City through respondent-driven sampling. We examined the prevalence of IDU sex partnerships among these non-IDU, the factors associated with having a past year IDU partner, and the independent association of HIV infection and IDU sex partnerships in multiple logistic regression. Of the 601 non-IDU in this analysis, 13.8% had a sex partner in the past year with a history of injection. IDU partnerships were significantly more common among women and those with higher levels of unprotected sex and drug and alcohol use. Overall, 7.0% tested positive for HIV. HIV prevalence was higher (p=0.07) for participants with IDU partners (9.6%) compared to those with no IDU partners (4.6%). In multiple logistic regression, participants with IDU partners were over twice as likely to be HIV-infected (p=0.08). Sex partnerships with IDU were common and may play an important role in heterosexual HIV transmission in areas with large IDU populations. Prevention interventions to encourage the disclosure of injection history and risk reduction specifically for those with IDU partners are indicated.
AB - Sex partnerships with injection drug users (IDU) are an understudied network-level risk factor for heterosexual HIV infection. Heterosexuals with no history of injection were recruited from high-risk areas in New York City through respondent-driven sampling. We examined the prevalence of IDU sex partnerships among these non-IDU, the factors associated with having a past year IDU partner, and the independent association of HIV infection and IDU sex partnerships in multiple logistic regression. Of the 601 non-IDU in this analysis, 13.8% had a sex partner in the past year with a history of injection. IDU partnerships were significantly more common among women and those with higher levels of unprotected sex and drug and alcohol use. Overall, 7.0% tested positive for HIV. HIV prevalence was higher (p=0.07) for participants with IDU partners (9.6%) compared to those with no IDU partners (4.6%). In multiple logistic regression, participants with IDU partners were over twice as likely to be HIV-infected (p=0.08). Sex partnerships with IDU were common and may play an important role in heterosexual HIV transmission in areas with large IDU populations. Prevention interventions to encourage the disclosure of injection history and risk reduction specifically for those with IDU partners are indicated.
UR - http://www.scopus.com/inward/record.url?scp=77949358362&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949358362&partnerID=8YFLogxK
U2 - 10.1089/apc.2009.0227
DO - 10.1089/apc.2009.0227
M3 - Article
C2 - 20214485
AN - SCOPUS:77949358362
SN - 1087-2914
VL - 24
SP - 175
EP - 181
JO - AIDS patient care and STDs
JF - AIDS patient care and STDs
IS - 3
ER -